UNSPSC 51452804: Eprinomectin

This classification denotes an antiparasitic agent with the molecular formula C49H73NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75KP30FD8O. The term Eprinomectin is an International Non-Proprietary Name or INN (see WHO INN reference publication, see WHO INN reference publication, Volume 10, No. 3, 1996, List 36.). Most nations schedule eprinomectin under HS 29419000 and SITC 54139. As of Q4 2014, EPRINOMECTIN remains the US FDA Preferred Term for this commodity.

Eprinomectin bears US NLM identifiers UMLS ID C0529813 and NCI Concept Code C83694. SMILES: CC1C=CC=C2COC3C2(C(C=C(C3O)C)C(=O)OC4CC(CC=C(C1OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)NC(=O)C)OC)OC)C)OC7(C4)C=CC(C(O7)C(C)C)C)O.

UNSPSC 51452804 Eprinomectin, a Commodity code, carries a mismatch between its nominal scope and recent state and local procurement activity. The code's name refers to a specific antiparasitic pharmaceutical active ingredient, yet the two recent opportunities tagged to it involve naloxone (an opioid antagonist) and antibiotic tablets (doxycycline and ciprofloxacin), with no mention of eprinomectin itself. State and local procurement offices appear to use this code loosely for pharmaceutical warehouse purchases and emergency health-response supplies rather than as a precise match to the ingredient name. The actual work being solicited includes bulk pharmaceutical procurement through piggyback cooperative contracts and direct county purchasing of naloxone and drug-deactivation systems for community health programs. Issuing bodies have included state health departments and county governments soliciting through competitive bidding processes such as Invitations for Bid and IFBs.

Recent opportunities show activity in Illinois and Florida. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over the contract life including renewals, for a 12-month initial term with two renewal options. Seminole County, Florida released an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually for quarterly delivery to the Seminole County Community Health Building with a response deadline of July 26, 2026, under a two-year contract with a one-year renewal option. Both procurements required full shipping and delivery cost inclusion and compliance with standard procurement certifications. If your firm pursues this code, verify that state and local buyers use it consistently for pharmaceutical supply categories and clarify scope with purchasing officers before bid preparation, given the apparent categorical looseness in recent tagging.